Towards an immunodiagnostic test for leprosy

Microbes and Infection

Volumn 8, Issue 8, 2006, Pages 2270-2276

  Aráoz, Romulo ^a   Honoré, Nadine ^a   Banu, Sayera ^b   Demangel, Caroline ^a   Cissoko, Yakouba ^c   Arama, Charles ^c   Mafij Uddin, Mohammad Khaja ^b   Abdul Hadi, S K ^d   Monot, Marc ^a   Cho, Sang Nae ^e   Ji, Baohong ^f   Brennan, Patrick J ^g   Sow, Samba ^h   Cole, Stewart T ^a  

^a INSTITUT PASTEUR   (France)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c UNIVERSITY OF BAMAKO   (Mali)

^d Leprosy Contr Inst and Hospital   (Bangladesh)

^e Yonsei University College of Medicine   (South Korea)

^f Association Française Raoul Follereau   (France)

^g Department of Environmental and Radiological Health Sciences   (United States)

^h Centre National d'Appui a la Lutte Contre la Maladie   (Mali)

Author keywords

Comparative genomics; Comparative proteomics; IFN ; Leprosy immunodiagnosis; Mycobacterium leprae; Phenolic glycolipid 1

Indexed keywords

ANTIGEN; BACTERIAL ANTIGEN; BCG VACCINE; EPITOPE; GAMMA INTERFERON; PHENOLIC GLYCOLIPID I;

ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; ASSAY; BANGLADESH; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENOMICS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; LEPROSY; MALI; MOUSE; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; SERODIAGNOSIS; T LYMPHOCYTE; TUBERCULOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOLOGIC TESTS; INTERFERON TYPE II; INTERFERON-GAMMA; LEPROSY; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM LEPRAE; PEPTIDES; T-LYMPHOCYTES;

CORYNEBACTERINEAE; MYCOBACTERIUM LEPRAE;

EID: 33748309125     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.04.002     Document Type: Article

References (33)

1. Meima A., Irgens L.M., van Oortmarssen G.J., Richardus J.H., and Habbema J.D. Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach. Int. J. Epidemiol. 31 (2002) 991-1000
2. WHO. Guide to eliminate leprosy as a public health problem. first ed. (2000), World Health Organization, Geneva
3. WHO. The global leprosy situation. In: WHO (Ed). WHO Leprosy Elimination Project: Status Report 2003 (2004), World Health Organization, Geneva, Switzerland 8-11
4. Ridley D.S., and Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 34 (1966) 255-273
5. Britton W.J., and Lockwood D.N. Leprosy. Lancet 363 (2004) 1209-1219
6. Jacobson R.R., and Krahenbuhl J.L. Leprosy. Lancet 353 (1999) 655-660
7. Anon. Report of the International Leprosy Association Technical Forum. Int. J. Lepr. Other Mycobact. Dis. 70 supp (2002) S1-S62
8. Buhrer-Sekula S., Cunha M.G., Foss N.T., Oskam L., Faber W.R., and Klatser P.R. Dipstick assay to identify leprosy patients who have an increased risk of relapse. Trop. Med. Int. Health 6 (2001) 317-323
9. Buhrer-Sekula S., Smits H.L., Gussenhoven G.C., et al. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J. Clin. Microbiol. 41 (2003) 1991-1995
10. Cho S.N., Cellona R.V., Villahermosa L.G., et al. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin. Diagn. Lab. Immunol. 8 (2001) 138-142
11. Cho S.N., Kim S.H., Cellona R.V., et al. Prevalence of IgM antibodies to phenolic glycolipid I among household contacts and controls in Korea and the Philippines. Lepr. Rev. 63 (1992) 12-20
12. Cole S.T., Eiglmeier K., Parkhill J., et al. Massive gene decay in the leprosy bacillus. Nature 409 (2001) 1007-1011
13. Brodin P., Rosenkrands I., Andersen P., Cole S.T., and Brosch R. ESAT-6 proteins: protective antigens and virulence factors?. Trends Microbiol. 12 (2004) 500-508
14. Sorensen A.L., Nagai S., Houen G., Andersen P., and Andersen A.B. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63 (1995) 1710-1717
15. Rothel J.S., and Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?. Expert Rev. Anti Infect. Ther. 3 (2005) 981-993
16. Ewer K., Deeks J., Alvarez L., et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361 (2003) 1168-1173
17. Araoz R., Honoré N., Cho S., et al. Antigen discovery: a postgenomic approach to leprosy diagnosis. Infect. Immun. 74 (2006) 175-182
18. Dockrell H.M., Brahmbhatt S., Robertson B.D., et al. A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents. Infect. Immun. 68 (2000) 5846-5855
19. Geluk A., Klein M.R., Franken K.L., et al. Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection. Infect. Immun. 73 (2005) 5636-5644
20. Spencer J.S., Dockrell H.M., Kim H.J., et al. Identification of Specific Proteins and Peptides in Mycobacterium leprae Suitable for the Selective Diagnosis of Leprosy. J. Immunol. 175 (2005) 7930-7938
21. Spencer J.S., Kim H.J., Marques A.M., et al. Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10. Infect. Immun. 72 (2004) 3161-3170
22. Hussain R., Kaleem A., Shahid F., et al. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J. Immunol. Methods 264 (2002) 95-108
23. Demangel C., Brodin P., Cockle P.J., et al. Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of CFP-10 and ESAT-6. Infect. Immun. 72 (2004) 2170-2176
24. Demangel C., Garnier T., Rosenkrands I., and Cole S.T. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect. Immun. 73 (2005) 2190-2196
25. Singh H., and Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17 (2001) 1236-1237
26. Desem N., and Jones S.L. Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin. Diagn. Lab. Immunol. 5 (1998) 531-536
27. Ravn P., Munk M.E., Andersen A.B., et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 12 (2005) 491-496
28. Amezcua M.E., Escobar-Gutierrez A., Barba-Rubio J., et al. Prospective immunological follow-up in household contacts of Mexican leprosy patients. Int. J. Lepr. Other Mycobact. Dis. 58 (1990) 651-659
29. Ulrich M., Smith P.G., Sampson C., et al. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Int. J. Lepr. Other Mycobact. Dis. 59 (1991) 405-415
30. Lee H.N., Embi C.S., Vigeland K.M., and White C.R. Concomitant pulmonary tuberculosis and leprosy. J. Am. Acad. Dermatol. 49 (2003) 755-757
31. Fine P.E., Sterne J.A., Ponnighaus J.M., and Rees R.J. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344 (1994) 1245-1249
32. Geluk A., van Meijgaarden K.E., Franken K.L., et al. Immunological cross reactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis. Scand. J. Immunol. 59 (2004) 66-70
33. Geluk A., van Meijgaarden K.E., Franken K.L., et al. Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis. Infect. Immun. 70 (2002) 2544-2548